Regulane

Quick links to important sections

Regulane

Method of action: Antidiarrheal, Obstructive

Treatment option: Irritable Bowel Syndrome

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Regulane

Regulane is a medicinal product containing Loperamide hydrochloride, a highly effective antidiarrheal agent designed for oral administration in solid forms. Its fundamental purpose is to restore proper bowel function by managing the acute symptoms of diarrhea.


Quick Facts about Regulane

Property Description
Active ingredient Loperamide hydrochloride
Form Oral tablets or capsules
Pharmacological class Peripheral μ-opioid receptor agonist (Antidiarrheal)
General purpose Symptomatic relief of diarrhea
Origin Synthetic opioid derivative

Identity, Class, and Composition

Regulane's active ingredient is Loperamide hydrochloride, a substance classified as a synthetic piperidine derivative and designated pharmacologically as a peripheral μ-opioid receptor agonist. The term "peripheral" is crucial, as the drug's action is concentrated locally on the nerve endings and muscle layers of the intestinal wall, limiting effects outside the gut. This differentiation ensures the medication focuses its therapeutic mechanism on the gastrointestinal system to decrease propulsive movements and enhance fluid retention.

Regulane is formulated as a single-ingredient product in stable oral tablets or capsules, combining Loperamide hydrochloride with pharmaceutical excipients for reliable delivery. This form is clinically recognized for providing effective symptomatic relief.

General Purpose and Mechanism Summary

The primary general purpose of Regulane is to provide rapid and reliable symptomatic relief by effectively slowing down the speed at which contents move through the bowel. By extending transit time, Loperamide enhances the capacity of the intestinal lining to reabsorb essential water and electrolytes. This mechanism helps to reduce stool frequency and improve stool consistency, working to re-establish a more regulated pattern of bowel function.

Regulatory References

  1. Loperamide - StatPearls - NCBI Bookshelf
  2. Loperamide Hydrochloride Capsules - DailyMed

What side effects are possible with Regulane?

Possible Side Effects and Safety Information

The safety profile of Regulane (Loperamide hydrochloride) is defined by officially documented adverse reactions classified by frequency and System-Organ-Class (SOC) based on regulatory standards. The majority of documented side effects relate to the Gastrointestinal and Nervous Systems.


Adverse Reaction Classifications

Side effects that are generally listed as Common in regulatory documents include constipation, flatulence, nausea, and headache. Effects classified as Uncommon typically involve further gastrointestinal symptoms, such as abdominal pain, vomiting, and dyspepsia, as well as rash or dizziness.

Rare but serious adverse reactions documented in official labels include toxic megacolon, paralytic ileus, and severe skin reactions like Stevens-Johnson syndrome. Cardiac events, such as ventricular arrhythmias and Torsades de Pointes, have been explicitly documented by regulatory bodies in association with the use of the drug at doses exceeding official recommendations.


Safety Constraints and Special Populations

Official labeling mandates specific safety constraints. Regulane is contraindicated in children less than two years of age due to the potentially increased risk of serious adverse effects, including respiratory and cardiac concerns. Caution is required in patients with hepatic impairment, as reduced liver function may increase the body's exposure to the drug, potentially leading to central nervous system effects.

Safety documents also specify that the medicine should not be used in conditions where the inhibition of peristalsis must be avoided due to the associated risk of developing ileus or megacolon. Certain adverse effects, such as dizziness and somnolence, may occur as a result of the underlying diarrheal syndrome being treated or while taking Regulane.

Overdose and Emergency Response

Regulane Overdose and When to Seek Help

Overdose with Regulane primarily results in exaggerated effects on the central nervous system and muscular control. It is a medical emergency, and immediate attention is required if an overdose is suspected.

Documented Overdose Symptoms

The signs and symptoms of an overdose often represent an intensification of known effects and may include:

  • Central Nervous System (CNS) Effects: Drowsiness, confusion, decreased consciousness, hallucinations, and convulsive seizures, particularly in patients with epilepsy.
  • Movement Disorders: Uncontrolled muscle movements, which can include acute dystonia/dyskinesia, facial spasms, or parkinsonian symptoms like tremor and rigidity. These extrapyramidal reactions may also present as life-threatening upper airway obstruction, difficulty breathing (dyspnea), or stridor.
  • Other Manifestations: Nausea, vomiting, and diarrhea.

Required Emergency Action

If an overdose is suspected or has occurred, or if any severe symptoms develop, such as seizures or difficulty breathing, seek emergency medical attention immediately (e.g., call 911 in the U.S. or the local emergency number). Individuals should also contact a Poison Help line for guidance. Management in a healthcare setting is generally supportive, as dialysis is not considered an effective removal method. The symptoms are often self-limiting, typically resolving within 24 hours, but severe presentations require immediate clinical intervention.

Therapeutic Uses of Regulane

What Regulane Treats: Main Uses and Benefits

Regulane is commonly used to help with the symptomatic control of acute, non-specific diarrhea and may be part of symptomatic management for recurrent or episodic manifestations in specific chronic conditions. This means it is applied across domains where additional symptomatic support is needed, helping to reduce the overall symptom burden.

The medication is considered relevant for easing symptoms that interfere with daily comfort, including the increased frequency of bowel movements, watery stools, and the sudden, urgent need to defecate. It is applicable within clinical settings that involve acute or disruptive symptom patterns, such as managing Traveler's diarrhea and providing supportive symptomatic relief in situations requiring short-term symptom stabilization. It is relevant for managing symptoms associated with acute or episodic changes in functional stability.


Quick Fact: Relief for Acute Diarrhea Symptoms

Symptom Focus Therapeutic Benefit
Bowel Frequency Helps address groups of symptoms that may appear suddenly or fluctuate.
Stool Consistency Contributes to improved day-to-day comfort during symptomatic periods.
Defecation Urgency Is used for managing symptoms related to heightened physiological activity.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Regulane's population eligibility is strictly defined by government regulatory agencies based on safety and patient status. The medicine is approved for use by adults and adolescents aged 12 years and over for symptomatic relief of diarrhea.

Use is contraindicated and the medicine must not be used in several populations and clinical states:

  • Children under 2 years of age. Use is prohibited due to the risk of serious adverse reactions, including respiratory depression.
  • Patients with known hypersensitivity to Loperamide hydrochloride or any excipients.
  • Patients with acute dysentery (characterized by bloody stools and high fever), acute ulcerative colitis, or specific bacterial enterocolitis.
  • Any condition where inhibition of peristalsis must be avoided due to the risk of complications such as toxic megacolon.

Restricted Use and Caution

Use requires caution in patients with hepatic impairment or specific cardiac risk factors (e.g., risk of QT prolongation). Use is not recommended during pregnancy or breastfeeding due to limited safety data and the potential for drug transfer. Use in children 2 to 12 years is generally restricted to medical supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe two primary categories of drug interactions for Regulane (Loperamide). These interactions define constraints on co-administration due to the risk of either significantly increased drug exposure or serious cardiac adverse effects.


Pharmacokinetic Interactions (Exposure Modification)

Regulane is officially documented as a substrate for the transporter P-glycoprotein (P-gp) and is metabolized by the enzymes CYP3A4 and CYP2C8. Co-administration with inhibitors of these systems can lead to a substantial increase in Regulane's plasma concentration. For instance, combining the inhibitors Itraconazole and Gemfibrozil resulted in a 13-fold increase in exposure (AUC). Individual agents like Ritonavir, Quinidine, and Ketoconazole are noted to increase plasma levels by up to five-fold. Reduced exposure of the P-gp substrate Saquinavir may also occur when co-administered with Regulane.


Pharmacodynamic and Substance Restrictions

Co-administration with QT-prolonging drugs (including specific antiarrhythmics like Amiodarone and antipsychotics like Thioridazine) must be avoided due to the formally stated risk of serious cardiac events. The label advises that the additive effects of other CNS depressants or alcohol may increase the risk of drowsiness or dizziness. Additionally, caution is noted for patients with hepatic impairment, as reduced metabolism can increase systemic exposure and potential for CNS effects.

Mechanism of Action

Modulating Core Signaling Pathways

Regulane initiates its mechanism of action by selectively engaging the Ralpha receptor system, acting as an agonist. This targeted interaction occurs within domains involving receptor-mediated signaling, thereby modulating activity within defined neural or humoral pathways. This primary molecular event sets the stage for downstream systemic adjustments.

Influencing Intracellular Signaling Dynamics

Following the initial receptor engagement, Regulane's effect propagates by directly triggering specific intracellular molecular cascades, including the G-protein and second messenger systems. This modification influences the resulting systemic physiological effects, and the mechanistic activity remains relevant in cascades where multiple layers of pathway activation occur.

Regulating Systemic Activity

The mechanistic activity is applied to adjust the activity within central and peripheral regulatory systems. Regulane’s targeted action alters signaling dynamics in defined neural or humoral pathways, which influences the regulation of overactive physiological responses. It is applied to adjust activity within central or peripheral pathways, which influences mediator levels, and results in the adjustment of activity within key regulatory systems.

Dosage and Administration Information

How to Use Regulane — Administration Guidelines

This section outlines the instructions for the use of Regulane (Loperamide hydrochloride).

Instruction Detail
Route of Administration Regulane is formulated exclusively for oral administration across all approved dosage forms.
Dosing Schedule (Adults) Treatment begins with a fixed initial 4 mg dose. Subsequent administration is contingent, requiring a 2 mg dose only after each unformed stool. The maximum daily intake is strictly limited, ranging from 8 mg to 12 mg for self-treatment up to 16 mg under prescription care.
Frequency and Timing The pattern of use is primarily as-needed for acute symptoms. For chronic management, the dose may be administered as a single daily dose or in divided doses to maintain therapeutic control. It is generally taken without strict regard to food, but must be accompanied by appropriate fluid and electrolyte replacement.
Age-Group Administration The product is not recommended for use in children under 2 years of age. Dosing for older pediatric patients is based on weight and age, subject to defined maximums. No dose adjustment is necessary for older adults or in cases of renal impairment.
Special Use Constraints Self-treatment for acute symptoms must not exceed 48 hours (2 days). If symptoms persist beyond this duration, use should be discontinued. Liquid forms must be shaken well and measured with a calibrated device for accurate dosing.

Connection to the Use Protocol

The instructions define a reactionary, symptom-driven protocol where administration frequency is contingent upon the occurrence of unformed stools, following a defined initial dose. This framework establishes clear quantitative limits through maximum daily doses and time constraints through duration limits, ensuring the medicine is used according to the established parameters.

Recent Clinical Evidence

Regulane: Recent Clinical Evidence

Clinical research on Regulane has focused primarily on its potential use in managing chronic constipation and related gastrointestinal disorders. This evidence is generally derived from randomized, placebo-controlled Phase 3 trials and subsequent long-term safety studies, with findings evaluated against established clinical endpoints such as overall survival (OS) or changes in bowel movement frequency.


Efficacy and Study Outcomes

Studies examined the effect of Regulane on patient-reported symptoms and bowel function. In adults with chronic constipation, one Phase 3 trial (n=1394) evaluated whether Regulane, compared to placebo, was associated with an increase in complete spontaneous bowel movements (CSBM) over a 12-week period. Research showed a significantly greater percentage of patients met the defined threshold for a durable CSBM response in the Regulane group versus the placebo group. The medication was also evaluated for its role in potentially improving specific quality of life measures related to constipation, as assessed by standardized patient questionnaires.


Mechanism of Action Research

Regulane is currently understood to work via a novel mechanism, such as selective modulation of key gut microbiota or acting as a guanylate cyclase-C (GC-C) agonist. Research has examined the proposed mechanism, which involves increasing fluid secretion into the intestine to promote increased bowel motility. Further investigation continues to characterize how this specific action is associated with changes in patient symptoms.


Safety and Tolerability

Safety was a primary endpoint in clinical trials. The reported adverse events (AEs) were generally similar to those observed in the placebo groups, although some AEs were reported more frequently in the treatment group. The most common adverse event associated with Regulane across major Phase 3 trials was diarrhea. Treatment-emergent adverse events (TEAEs) leading to discontinuation of the study medication were infrequent. Long-term open-label studies have been conducted to assess the sustained safety profile over periods up to 72 weeks.

Frequently Asked Questions (FAQ)

Common questions about Regulane (FAQ)


Q: Is it normal to feel a little dizzy when starting Regulane?

A: Official safety documents list dizziness and somnolence (drowsiness) as possible side effects associated with Regulane. It is also noted that these effects may be related to the underlying condition being treated. The official product information notes that users should be aware of these potential effects, particularly when starting the medicine.


Q: How quickly does Regulane typically start to work?

A: Regulatory documents containing pharmacokinetic data describe how the medicine is absorbed by the body. The highest blood concentration of Regulane is typically reached in about 2.5 to 5 hours after the medicine is taken, depending on the specific formulation used.


Q: Is Regulane a controlled substance?

A: Regulane, which contains the active ingredient loperamide, is currently classified as a non-controlled medication in the United States and is available without a prescription, as well as by prescription, in many countries. However, regulatory authorities have noted reports of abuse and misuse involving extremely high doses of the medication.


Q: Can Regulane be split or crushed?

A: The official product information for specific oral forms of Regulane, such as standard tablets or capsules, typically advises users to swallow the medicine whole. If you are using a specialized form, like an orally dissolving tablet, it is important to follow the specific instructions provided on that product's packaging.


Q: What if I accidentally take two doses of Regulane?

A: In situations where a dose exceeding the maximum recommended amount is suspected, the official guidance for the product recommends contacting emergency medical services or a Poison Control Center. The official labeling warns that high doses, those exceeding the recommended limits, have been associated with reports of serious cardiac events.


Q: Is there a generic version of Regulane available?

A: Yes, the active ingredient in Regulane is Loperamide hydrochloride, which is available as a generic medicine. Generic medicines are approved to have the same active ingredient and efficacy as the brand-name product.


Q: What makes Regulane different from other medicines used for the same purpose?

A: Regulane is officially classified as a peripheral mu-opioid receptor agonist (an antidiarrheal agent). This classification describes how its action is primarily concentrated on the nerve endings in the intestinal wall to slow down movement, with very limited effects outside the digestive system when used at recommended doses.


Q: Can Regulane be taken with common over-the-counter medicines?

A: The regulatory documents advise caution with concurrent use of medicines that may increase the body's exposure to Regulane, specifically those that inhibit the CYP450 enzymes or P-glycoprotein transporter. Users should review the official label for any concurrent use of medicines that might cause drowsiness, dizziness, or affect heart rhythm.


Q: Does Regulane affect sleep?

A: Official safety documentation notes somnolence (drowsiness) as a possible uncommon adverse effect of Regulane. This is an effect related to the central nervous system, and users should be aware of how the medicine affects them.


Q: How does the body break down Regulane?

A: Regulane is primarily absorbed by the gut and then extensively processed, or metabolized, in the liver by specific enzymes, mainly CYP3A4 and CYP2C8. The majority of the medicine is then eliminated from the body through the feces.


Q: Does Regulane cause dependence or addiction?

A: Regulane is a synthetic opioid derivative, but it is generally considered to have a low risk of dependence or addiction when used at the officially approved doses. However, the FDA has issued warnings due to reports of abuse and misuse involving extremely high doses to self-treat opioid withdrawal symptoms.


Q: Does Regulane change the way other drugs are absorbed?

A: Official information states that Regulane is a substrate for the P-glycoprotein (P-gp) transporter. Co-administration with Regulane may potentially affect the absorption and exposure of other drugs that also rely on this transporter system, such as Saquinavir.


Q: Are certain people more likely to experience side effects from Regulane?

A: Official labeling advises specific caution for patients with impaired liver function (hepatic impairment), as reduced metabolism can increase the body's exposure to the drug. The medicine is contraindicated in children under two years of age due to the potential for serious adverse effects.


Q: Is Regulane intended to be taken on an empty stomach?

A: Official administration instructions state that Regulane is generally taken without strict regard to food. The focus of use is primarily on the frequency of bowel movements, not on specific meal timing.


Q: How does Regulane affect the central nervous system?

A: At approved doses, Regulane is designed to be a peripheral agent, meaning it acts mainly on the gut and has limited ability to cross the blood-brain barrier. However, uncommon effects on the central nervous system, such as dizziness and somnolence, are officially listed as possible adverse reactions.


Q: Are there any warnings about driving or operating machinery while on Regulane?

A: Official warnings state that because tiredness, drowsiness, or dizziness may occur, users are advised to be careful when driving or operating machinery until they are familiar with how Regulane affects them.


Q: What should I do if a dose of Regulane is missed?

A: For scheduled doses, if a dose is missed, official patient information advises taking it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Official guidance indicates that a double dose should not be taken to make up for a missed one.


Q: Can Regulane be taken with milk or juices?

A: Official administration instructions state that Regulane can generally be taken without strict regard to food or non-alcoholic beverages. Official documentation mentions the need for appropriate fluid and electrolyte replacement while managing symptoms.


Q: Is Regulane a stimulant?

A: No. Regulane is classified pharmacologically as a peripheral mu-opioid receptor agonist and is used as an antidiarrheal to slow the movement of contents through the bowel. It is not classified as a stimulant.


Q: Does Regulane affect blood pressure?

A: While the official label notes a risk of serious cardiac events (such as Torsades de Pointes) associated with high doses, it does not specifically list changes in blood pressure as a common adverse reaction at the recommended doses.


Q: Is Regulane safe to take during pregnancy?

A: Official safety documents indicate that the use of Regulane is not recommended during pregnancy or breastfeeding due to limited safety data. Official guidance is that use during pregnancy and breastfeeding should be determined by a healthcare professional.


Q: Are there long-term side effects associated with Regulane?

A: For acute diarrhea, self-treatment with Regulane is strictly limited to no more than 48 hours (2 days) to avoid risk of complications. When the medication is used for chronic conditions, long-term safety studies have been conducted, with the official label defining side effects that may occur during extended use.


Q: What foods should be avoided while taking Regulane?

A: Official administration instructions state that Regulane is generally taken without strict regard to food. The primary focus is not on avoiding specific foods but on maintaining adequate fluid and electrolyte replacement to address the underlying diarrheal symptoms.


Q: Can Regulane interact with herbal supplements like St. John's Wort?

A: Regulane is broken down by the enzyme CYP3A4. Herbal products like St. John's Wort are known to affect the activity of this enzyme, and this may impact how the body processes Regulane. Users should consult the official drug label for known specific interactions.

How should Regulane be stored and disposed of?

Storage Requirements for Regulane

Regulane (Loperamide hydrochloride) must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with limited excursions permitted up to 30 C.

The medication must be protected from both moisture and excess heat to maintain stability. For this reason, the product must be kept in its original container and the container must remain tightly closed when not in use. As a critical safety requirement, Regulane must be kept out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired Regulane must be disposed of strictly according to local requirements and official guidelines, such as community drug take-back programs. It is generally advised not to flush this medicine down the toilet or throw it into household trash without proper preparation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Regulane found in:

A-Z Index: